{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "12442595", "DateCompleted": {"Year": "2003", "Month": "01", "Day": "16"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["rus"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0233-528X", "JournalIssue": {"Volume": "36", "Issue": "4", "PubDate": {"Year": "2002"}}, "Title": "Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine", "ISOAbbreviation": "Aviakosm Ekolog Med"}, "ArticleTitle": "[Peripheral blood morphology during chronic bronchitis complicated by the effect of ozone].", "Pagination": {"StartPage": "60", "EndPage": "65", "MedlinePgn": "60-5"}, "Abstract": {"AbstractText": ["In workers afflicted with chronic bronchitis (ChB) after breathing ozone leukocytosis gives place to leukopenia against development of lympho-, monocyto- and neutropenia. In contrast to the workers, in citizens who have not previously contacted ozone chronic obstructive bronchitis is characterized by leukocytosis with less expressed lympho- and neutropenia. Changes in peripheral blood in ChB patients (development of leuko-, lympho-, monocyto- and neutropenia) grow drastically in 5-8 years of ozone inhalation."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Abdrashitova", "ForeName": "N F", "Initials": "NF"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Romanov", "ForeName": "Iu A", "Initials": "IuA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Irikov", "ForeName": "O A", "Initials": "OA"}], "PublicationTypeList": ["English Abstract", "Journal Article"], "VernacularTitle": "Morfologiia periferichesko\u012d krovi pri khronicheskom bronkhite, oslozhnennom de\u012dstviem ozona."}, "MedlineJournalInfo": {"Country": "Russia (Federation)", "MedlineTA": "Aviakosm Ekolog Med", "NlmUniqueID": "9305904", "ISSNLinking": "0233-528X"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["blood", "therapy"], "DescriptorName": "Bronchitis"}, {"QualifierName": [], "DescriptorName": "Chronic Disease"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2002", "Month": "11", "Day": "22", "Hour": "4", "Minute": "0"}, {"Year": "2003", "Month": "1", "Day": "17", "Hour": "4", "Minute": "0"}, {"Year": "2002", "Month": "11", "Day": "22", "Hour": "4", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12442595"]}}], "PubmedBookArticle": []}